MedPath

Prcl Research Inc.

🇨🇦Canada
Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:1
Completed:2

Trial Phases

2 Phases

Phase 1:2
Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Phase 1
2 (66.7%)
Phase 2
1 (33.3%)

A Study of PRCL-02 in Moderate to Severe Chronic Plaque Psoriasis

Phase 2
Completed
Conditions
Plaque Psoriasis
Psoriasis Vulgaris
Interventions
Drug: Placebo
First Posted Date
2018-08-03
Last Posted Date
2020-03-30
Lead Sponsor
PRCL Research Inc.
Target Recruit Count
92
Registration Number
NCT03614078
Locations
🇨🇦

Wiseman Dermatology Research Inc., Winnipeg, Manitoba, Canada

🇨🇦

SimcoDerm Medical and Surgical Dermatology, Barrie, Ontario, Canada

🇨🇦

DermEffects, London, Ontario, Canada

and more 13 locations

A Study of PRCL-02 in Healthy Volunteers and Plaque Psoriasis

Phase 1
Completed
Conditions
Psoriasis
Interventions
Drug: Placebo Oral Tablet
First Posted Date
2017-02-23
Last Posted Date
2018-03-07
Lead Sponsor
PRCL Research Inc.
Target Recruit Count
50
Registration Number
NCT03062618
Locations
🇨🇦

Dr. Chih-ho Hong Medical Inc, Surrey, British Columbia, Canada

🇨🇦

Lynde Centre for Dermatology, Markham, Ontario, Canada

🇨🇦

SKiN Centre for Dermatology, Peterborough, Ontario, Canada

and more 3 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.